About: Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?”

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?” Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?”
Creator	Fernandes, Timothy Kim, Nick Papamatheakis, Demosthenes Poch, David
Source	Medline; PMC
abstract	covid:4358587b9562617dab15a5935c5f2ec9cb9888cb#abstract
has issue date	2020-05-14(xsd:dateTime)
bibo:doi	10.1177/2045894020925761
bibo:pmid	32489645
has license	cc-by-nc
sha1sum (hex)	4358587b9562617dab15a5935c5f2ec9cb9888cb
schema:url	https://doi.org/10.1177/2045894020925761
resource representing a document's title	Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?”
has PubMed Central identifier	PMC7238818
has PubMed identifier	32489645
schema:publication	Pulm Circ
resource representing a document's body	covid:4358587b9562617dab15a5935c5f2ec9cb9888cb#body_text
is schema:about of	named entity 'pulmonary arterial hypertension' named entity 'Acute respiratory distress syndrome' named entity 'COVID-19' named entity 'targeted therapies' named entity 'PAH' named entity 'PAH' named entity 'COVID-19' named entity 'social distancing' named entity 'PAH' named entity 'COVID-19' named entity 'pulmonary hypertension' named entity 'PAH' named entity 'hypoxemia' named entity 'serologic tests' named entity 'COVID-19' named entity 'medical conditions' named entity 'PAH' named entity 'COVID-19' named entity 'COVID19' named entity 'Wuhan' named entity 'medical therapy' named entity 'ARDS' named entity 'PAH' named entity 'PAH' named entity 'PDE' named entity 'phosphodiesterase type 5 inhibitor' named entity 'PAH' named entity 'perfusion' named entity 'PAH' named entity 'SARS-CoV2' named entity 'hypoxemic' named entity 'hand hygiene' named entity 'social media' named entity 'case-fatality rate' named entity 'PAH' named entity 'intubation' named entity 'response bias' named entity 'COVID-19' named entity 'COVID-19' named entity 'PAH' named entity 'COVID-19' named entity 'intubation' named entity 'prostanoids' named entity 'China' named entity 'PAH' named entity 'COVID-19' named entity 'COVID-19 infection' named entity 'COVID-19' named entity 'PHA' named entity 'Pulmonary Hypertension Association' named entity 'PAH' named entity 'pulmonary arterial hypertension' named entity 'lung parenchyma' named entity 'PAH' named entity 'PAH' named entity 'vasoconstrictive' named entity 'COVID-19' named entity 'COVID-19' named entity 'ARDS' named entity 'COVID-19' named entity 'targeted therapies' named entity 'hypoxemia' named entity 'endothelin receptor antagonists' named entity 'PAH' named entity 'social distancing' named entity 'PAH' named entity 'sildenafil' named entity 'Italy' named entity 'critical illness' named entity 'PAH' named entity 'infection' named entity 'PAH' named entity 'intubation' named entity 'March 2020' named entity 'PAH' named entity 'LOWER' named entity 'PULMONARY ARTERIAL HYPERTENSION' named entity 'pulmonary arterial hypertension'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software